Learning Objectives:

1.Understand the rationale and evidence for quadruplet therapy in myeloma
2. Evaluate the role of autologous stem cell transplant in frontline myeloma therapy
3. Understand how to define and treat high risk myeloma
4. Understand the impact of minimal residual disease in myeloma therapy

 

 

Session date: 
Wednesday, May 19, 2021 - 4:00pm to 5:00pm
Location: 
UCMC
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Andrzej Jakubowiak, MD, PhD